These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11531742)

  • 1. Psychotropic analgesic nitrous oxide (PAN) for hyperactivity.
    de Wet J; Lichtigfeld FJ; Gillman MA
    Aust N Z J Psychiatry; 2001 Aug; 35(4):543-4. PubMed ID: 11531742
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide in alcohol and drug withdrawal.
    Lichtigfeld FJ; Gillman MA
    Clin Neuropharmacol; 1996 Jun; 19(3):246-51. PubMed ID: 8726543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state.
    Gillman MA; Lichtigfeld FJ
    J Subst Abuse Treat; 2002 Apr; 22(3):129-34. PubMed ID: 12039615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symposium: psychotropic analgesic nitrous oxide (PAN): mechanisms of action and use for treating substance abuse withdrawal presented at 8th world congress of biological psychiatry Vienna (2 July 2005) in memoriam Frederick J Lichtigfeld (1933-2005).
    Gillman MA
    Int J Neurosci; 2006 Jul; 116(7):827-33. PubMed ID: 16861148
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychotropic analgesic nitrous oxide for alcohol withdrawal.
    Gillman MA
    Am J Health Syst Pharm; 2008 Dec; 65(23):2205, 2210; author reply 2210. PubMed ID: 19020183
    [No Abstract]   [Full Text] [Related]  

  • 6. Enlarged double-blind randomised trial of benzodiazepines against psychotropic analgesic nitrous oxide for alcohol withdrawal.
    Gillman MA; Lichtigfeld FJ
    Addict Behav; 2004 Aug; 29(6):1183-7. PubMed ID: 15236821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic nitrous oxide: an opioid treatment for migraine.
    Gillman MA; Lichtigfeld FJ
    Am J Emerg Med; 2000 Jul; 18(4):501. PubMed ID: 10919548
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical role and mechanisms of action of analgesic nitrous oxide.
    Gillman MA; Lichtigfeld FJ
    Int J Neurosci; 1998 Feb; 93(1-2):55-62. PubMed ID: 9604169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotropic analgesic nitrous oxide for alcoholic withdrawal states.
    Gillman MA; Lichtigfeld FJ; Young TN
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005190. PubMed ID: 17443576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technique for the administration of nitrous oxide/oxygen sedation to ensure psychotropic analgesic nitrous oxide (PAN) effects.
    Clark MS; Campbell SA; Clark AM
    Int J Neurosci; 2006 Jul; 116(7):871-7. PubMed ID: 16861152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the analgesic potency of xenon and nitrous oxide in humans evaluated by experimental pain.
    Petersen-Felix S; Luginbühl M; Schnider TW; Curatolo M; Arendt-Nielsen L; Zbinden AM
    Br J Anaesth; 1998 Nov; 81(5):742-7. PubMed ID: 10193287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical observation and nursing of nitrous oxide inhalation to ease delivery pain].
    Yin Y; Chen PS; Huang ML
    Zhonghua Hu Li Za Zhi; 1997 Dec; 32(12):698-700. PubMed ID: 10455599
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitrous oxide is not beneficial for breakthrough cancer pain.
    Enting RH; Oldenmenger WH; van der Rijt CC; Koper P; Lieverse J; Sillevis SP
    Palliat Med; 2002 May; 16(3):257-9. PubMed ID: 12047005
    [No Abstract]   [Full Text] [Related]  

  • 14. Incident pain.
    Cleary JF
    Palliat Med; 2005 Jan; 19(1):1-2. PubMed ID: 15690861
    [No Abstract]   [Full Text] [Related]  

  • 15. Nitrous oxide lacks the antinociceptive effect on the tail flick test in newborn rats.
    Fujinaga M; Doone R; Davies MF; Maze M
    Anesth Analg; 2000 Jul; 91(1):6-10. PubMed ID: 10866878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Not Available].
    Oliveira G
    Rev Infirm; 2016 Apr; (220):51-2. PubMed ID: 27063888
    [No Abstract]   [Full Text] [Related]  

  • 17. Discussion on integrated pharmacologic treatment of attention-deficit hyperactivity disorder (ADHD).
    Hendren RL
    Essent Psychopharmacol; 2005; 6(5):291-300. PubMed ID: 16222913
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychopharmacotherapy of Attention Deficit-Hyperactivity Disorder in Children with Comorbid Conditions.
    Naguy A
    Pediatr Neurol; 2018 May; 82():7-12. PubMed ID: 29678368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of nitrous oxide during lumbar punctures: A call for nitrous oxide in pediatric oncology clinics.
    Livingston M; Lawell M; McAllister N
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28475231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of nitrous oxide and oxygen in paediatric emergency departments].
    Bourgade C; Droz N; Cotillon M; De Groc T; Cojocaru B
    Soins Pediatr Pueric; 2016; 37(291):39-41. PubMed ID: 27444537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.